Oculus Innovative Sciences is a commercial healthcare company focused on designing, producing and marketing drugs, devices and nutritional products that are innovative, safe and effective. The company is engaged in pioneering innovative solutions in multiple markets, including dermatology, surgical, wound care and animal healthcare, and has commercialized products in the U.S., Europe, India, China, Mexico and select Middle East countries. For more information, visit the company’s Web site at www.oculusis.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: